MacroGenics, Inc. (MGNX), Takeda Pharmaceutical Co. Ltd. (TKPYY) Draw Up $1.6B DART Pact
Allergan Inc. (AGN) Quietly Leases A 90,000 Square Feet Space In Texas
Boehringer Ingelheim Corporation To Create 100 New Jobs With $125 Million+ Site Expansion
FDA Slaps Valeant (VRX) With A Warning Letter
Bristol-Myers Squibb Company (BMY) Sheds $1.4B In Pension Liabilities By Transferring Risk To Prudential
Novartis AG (NVS) Ditches Hepatitis C Drug Dreams, Breaks $440 Million Enanta Pharmaceuticals, Inc. Deal
SF Biotech FibroGen, Inc. Plots $125 Million IPO As It Muscles Its Way Into Fibrosis
Novartis AG (NVS) To Roll Out 15 Abstracts At EADV
Endocyte, Inc. (ECYT) Faces Big Decisions On Cancer Drug Vintafolide
Akorn, Inc. (AKN) Ponies Up $45 Million Cash For Sunovion Pharmaceuticals Inc.'s Xopenex® (levalbuterol HCI) Inhalation Solution
After Snagging 18 Products From AstraZeneca PLC (AZN), IGI Laboratories, Inc. Grabs Two More From Valeant (VRX)
Portola Pharmaceuticals, Inc.'s ANNEXA™ Reverses Effect Of Anti-Clotting Drugs In Phase 3 Study
Abstracts For Merck & Co. (MRK), Gilead Sciences, Inc. (GILD) And AbbVie (ABBV) Look Promising, Says ISI
Ardelyx Inc. (ARDX) Looks Good After Tenanpanor Results: Citi Analysts
GE Corporation (GE), University of California, San Francisco (UCSF), Agencies Partner Up To Define, Attack Traumatic Brain Injuries
Oncore Grabs Enantigen Therapeutics For Undisclosed Amount
Ardelyx Inc. (ARDX) Irritable Bowel Syndrome Drug Succeeds In Phase 2b Trial
Islet Sciences, BHV Pharma, Inc. Merges; Combined Company To Be Named Avogenx
See All News >
//-->